Investors & News

Investor Relations

Stock price graph
     

MAP Pharmaceuticals is an innovative drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients' hands by enhancing how proven drugs perform, through targeted dosing regimens and novel delivery systems. MAP Pharmaceuticals' goal is to develop treatments that provide patients with greater control, improved efficacy and fewer side effects.

Recent Releases

Feb 7, 2013
Allergan, Inc. and MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Period Under Hart-Scott-Rodino Act

Jan 22, 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.

Jan 2, 2013
MAP Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

View all »   RSS

 

 

Stock Quote
(NASDAQ:MAPP)

Price:
24.98
Change:
- 0.02
Day High:
25.01
Day Low:
24.98
Volume:
1,074,100
4:11 PM ET on Mar 1, 2013
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools